IMC Chicago’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.09M Buy
88,700
+53,500
+152% +$3.04M ﹤0.01% 1932
2026
Q1
$2.26M Sell
35,200
-39,000
-53% -$3.56M ﹤0.01% 2453
2025
Q4
$9.65M Buy
74,200
+9,000
+14% +$1.24M ﹤0.01% 1248
2025
Q3
$7.02M Sell
65,200
-49,000
-43% -$5.34M ﹤0.01% 1349
2025
Q2
$10.5M Buy
114,200
+89,300
+359% +$7.01M ﹤0.01% 993
2025
Q1
$2.21M Buy
+24,900
New +$2.16M ﹤0.01% 1739

Other funds holding WGS

IMC Chicago's WGS Position: Q2 2026 in Review

IMC Chicago increased its GeneDx Holdings (WGS) stake by 176% in Q2 2026, buying an estimated $463K and bringing the position to 12,794 shares worth $878K. The position accounts for ﹤0.01% of the portfolio, ranked #4014.

IMC Chicago first reported a position in WGS in Q1 2026 and has held it in 2 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • IMC Chicago held 12,794 shares of GeneDx Holdings worth $878K as of Q2 2026.
  • IMC Chicago bought 8,151 GeneDx Holdings shares in Q2 2026, an estimated $463K.
  • GeneDx Holdings made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4014 holding.
  • IMC Chicago first reported a position in GeneDx Holdings in Q1 2026 and has held it in 2 quarters since.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.